La popularidad de la telemedicina aumentó durante la pandemia
MARTES, 8 de noviembre de 2022 (HealthDay News) — La telemedicina se hizo común durante la pandemia, y esto podría haber cambiado la opinión de los pacientes sobre el uso de la tecnología como forma de comunicarse con los médicos, sugiere un estudio …
Learn MoreFatal Heart Infections Linked to Opioid Abuse Have Tripled Among Young Americans
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — The U.S. opioid epidemic has been heartbreaking — literally.Young adults’ risk of dying from a devastating infection of the heart has doubled to tripled in the United States during the past two decades, a ne…
Learn MoreU.S. Deaths From Infective Endocarditis Increasing in the Young
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — The risk for death from infective endocarditis (IE) increased twofold among young U.S. residents aged 15 to 44 years during 1999 to 2020, according to a research letter published online Nov. 9 in the Journal…
Learn MoreU.S. Deaths From Infective Endocarditis Increasing in the Young
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — The risk for death from infective endocarditis (IE) increased twofold among young U.S. residents aged 15 to 44 years during 1999 to 2020, according to a research letter published online Nov. 9 in the Journal…
Learn MoreASN: Empagliflozin Cuts Risk for Progression in CKD
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with chronic kidney disease at risk for progression, the risk for progression of kidney disease or death from cardiovascular causes is reduced with empagliflozin treatment, according to a study …
Learn MoreUnexplained Outpatient Electrolyte Abnormality May Signal Eating Disorder
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — Nearly one in five individuals diagnosed with an eating disorder had a preceding outpatient electrolyte abnormality, according to a study published online Nov. 8 in JAMA Network Open.Gregory L. Hundemer, M.D…
Learn MoreASN: Discontinuation of RAS Inhibitors Does Not Increase eGFR in CKD
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with advanced and progressive chronic kidney disease, discontinuation of treatment with renin-angiotensin system (RAS) inhibitors is not associated with a difference in the long-term rate of dec…
Learn MoreASN: Discontinuation of RAS Inhibitors Does Not Increase eGFR in CKD
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with advanced and progressive chronic kidney disease, discontinuation of treatment with renin-angiotensin system (RAS) inhibitors is not associated with a difference in the long-term rate of dec…
Learn MoreFDA Warns of Animal Tranquilizer in Illicit Drugs
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Tuesday warned health care workers to look out for patients who may have been exposed to a potentially deadly animal sedative, possibly through illicit drug use.The v…
Learn MoreFDA Warns of Animal Tranquilizer in Illicit Drugs
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Tuesday warned health care workers to look out for patients who may have been exposed to a potentially deadly animal sedative, possibly through illicit drug use.The v…
Learn More